(Q37476820)

English

Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis

scientific article published on December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

0 references

0 references

postmenopausal osteoporosis

1 reference

based on heuristic

inferred from title

author name string

Johann D Ringe

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Gerd Möller

2

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

publication date

1 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Rheumatology International

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

213-221

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

https://scigraph.springernature.com/pub.10.1007/s00296-009-0940-5

0 references

Medication compliance and persistence: terminology and definitions

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-0940-5

21 January 2018

Why we need observational studies to evaluate the effectiveness of health care

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-0940-5

21 January 2018

Study subjects and ordinary patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current and emerging therapies in osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esophagitis associated with the use of alendronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of risedronate to alendronate and calcitonin for early reduction of nonvertebral fracture risk: results from a managed care administrative claims database

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance with osteoporosis drug therapy and risk of fracture

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates: a review of their pharmacokinetic properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bias and causal associations in observational research.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance with drug therapies for the treatment and prevention of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of treatment benefit due to low compliance with bisphosphonate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of compliance with osteoporosis treatment and its consequences in a managed care population

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerability of risedronate in postmenopausal women intolerant of alendronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disintegration/dissolution profiles of copies of Fosamax (alendronate).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seven years of treatment with risedronate in women with postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2006 DVO-guideline for prevention, diagnosis, and therapy of osteoporosis for women after menopause, for men after age 60 executive summary guidelines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of risedronate on clinical vertebral fractures within six months.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of osteoporosis: current status and recent advances

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upper gastrointestinal tract safety of daily oral risedronate in patients taking NSAIDs: a randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Percutaneous vertebroplasty immediately relieves pain of osteoporotic vertebral compression fractures and prevents prolonged immobilization of patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19430791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00296-009-0940-5

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37476820&oldid=1707199815"